David Geffen School of Medicine at University of California, Los Angeles — Los Angeles, California

David Geffen School of Medicine at University of California, Los Angeles is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

David Geffen School of Medicine at University of California, Los Angeles has participated in 5 clinical trials with 2 currently active.

Therapeutic areas: Smoking Cessation, Hereditary Hemorrhagic Telangiectasia, Idiopathic Pulmonary Fibrosis.

Sponsors: Pfizer, Unity Health Toronto, Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for David Geffen School of Medicine at University of California, Los Angeles?

David Geffen School of Medicine at University of California, Los Angeles has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has David Geffen School of Medicine at University of California, Los Angeles conducted?

David Geffen School of Medicine at University of California, Los Angeles has 5 clinical trials on record, with 2 currently active. Their work covers Smoking Cessation, Hereditary Hemorrhagic Telangiectasia, Idiopathic Pulmonary Fibrosis.

Is David Geffen School of Medicine at University of California, Los Angeles accredited by Crixeo Health?

David Geffen School of Medicine at University of California, Los Angeles has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about David Geffen School of Medicine at University of California, Los Angeles?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.